0 Commentaires
0 Parts
139 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Antibody-Drug Conjugate (ADC) Oncology Market: Trends and Growth OpportunitiesExecutive Summary Antibody-Drug Conjugate (ADC) Oncology Market Research: Share and Size Intelligence CAGR Value The global Antibody-Drug Conjugate (ADC) oncology market size was valued at USD 1.28 billion in 2025 and is expected to reach USD 2.91 billion by 2033, at a CAGR of 10.80% during the forecast period The scope of this Antibody-Drug Conjugate...0 Commentaires 0 Parts 185 Vue 0 Aperçu
-
Cancer Research Breakthrough: Evaluating the Critical Role of Spheroids and Organoids in Personalized Oncology and Therapy Development.For 3D cell culture models to transition from specialized research tools to mainstream industry standards in pharmaceutical R&D, they must be scalable for High-Throughput Screening (HTS). The inherent complexity and manual handling requirements of 3D cultures—such as precise media changes, matrix embedding, and complex imaging—initially made them difficult to integrate into the...0 Commentaires 0 Parts 757 Vue 0 Aperçu
-
CD47 Targeting Therapeutics Market Analysis and Immuno-Oncology LandscapeThe CD47 Targeting Therapeutics Market analysis highlights the growing significance of CD47 as a promising target in cancer immunotherapy. CD47, often referred to as the “don’t eat me” signal, is overexpressed in many cancer cells, allowing them to evade immune system clearance. Therapeutics targeting CD47 aim to block this signal, enabling macrophages to recognize and...0 Commentaires 0 Parts 383 Vue 0 Aperçu
-
CDx Beyond Oncology: Expanding into Rare Diseases and Neurodegenerative Disorders – New Market FrontiersCompanion diagnostics (CDx) are transcending their oncology roots, expanding into new disease areas like rare genetic disorders and neurodegenerative conditions, where precise patient stratification is critical. This shift is driven by advancements in biomarker discovery and growing demand for personalized treatments in underserved fields. As CDx proves its utility beyond cancer, the market is...0 Commentaires 0 Parts 844 Vue 0 Aperçu
-
Global Immuno-Oncology Assay Market Forecast 2030: Growth Trends, Key Players & Future Outlook | MarkNtelAs per MarkNtel Advisors The Global Immuno-Oncology Assay Market size was valued at around USD 3.62 billion in 2024 and is projected to reach USD 6.86 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.25% during the forecast period, i.e., 2025-30. Global Immuno-Oncology Assay Market Systems Market Outlook: The Russian Seed Market is rapidly...0 Commentaires 0 Parts 720 Vue 0 Aperçu
-
Hadron Therapy Market Growth Driven by Demand for Targeted Oncology SolutionsThe continuous advancement in targeted cancer therapy solutions has placed hadron-based radiation techniques at the forefront of next-generation oncology care. The Hadron Therapy Market research shows that proton and carbon-ion therapies are expanding rapidly due to their superior delivery accuracy and reduced side effects compared to conventional radiotherapy. As the global burden of cancer...0 Commentaires 0 Parts 900 Vue 0 Aperçu
-
Harnessing Quantitative Information for Strategic Decisions: Analyzing China Companion Diagnostics Oncology Market DataThe effective utilization of granular, verified information is the bedrock of successful commercial strategy in China’s oncology diagnostics sector. China Companion Diagnostics Oncology Market Data provides the quantitative backbone necessary to move beyond anecdotal evidence and make evidence-based decisions regarding product development, pricing, and distribution. This data...0 Commentaires 0 Parts 898 Vue 0 Aperçu
-
Is the North America PDX Models Market Redefining Precision Oncology Research?Market Trends Shaping Executive Summary North America Patient Derived Xenograft (PDX) Models Market Size and Share The North America Patient Derived Xenograft (PDX) models market size was valued at USD 103.42 billion in 2024 and is expected to reach USD 370.69 billion by 2032, at a CAGR of 17.30% during the forecast period This North America...0 Commentaires 0 Parts 680 Vue 0 Aperçu
-
Leveraging Clinical and Commercial Data: The Role of Real-World Evidence and Test Utilization Metrics in the China Companion Diagnostics Oncology MarketThe China Companion Diagnostics (CDx) Oncology Market is undergoing a transformational surge, positioning the nation as a global powerhouse in precision medicine. This acceleration is underpinned by a critical convergence of factors: an immense and growing domestic cancer burden, ambitious national health initiatives promoting personalized treatment, and a streamlined yet rigorous...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Leveraging Comprehensive Information for Informed Decisions in Rare Neuro-Oncology TreatmentThe foundation of effective treatment and commercial strategy in the Subcutaneous Neurofibroma Market lies in the quality and accessibility of market Data, which encompasses a broad spectrum of epidemiological, clinical, and financial information. This Data includes detailed patient registry information, tumor growth rates, surgical outcomes, long-term safety Data for systemic therapies,...0 Commentaires 0 Parts 767 Vue 0 Aperçu
-
Market Trend: Albumin Nanoparticles in Targeted Oncology Drug Delivery SystemsThe field of oncology in the United States is witnessing a revolution in drug delivery through the use of albumin-bound technologies. Use cases for these specific technologies involve the encapsulation of potent chemotherapy agents within protein nanoparticles to improve their solubility and targeting capabilities. By leveraging the natural transport properties of human serum albumin, these...0 Commentaires 0 Parts 473 Vue 0 Aperçu
-
Alpha Emitter Market: Tripling to $3.09 Billion by 2032ntrospective Market Research (IMR) has published its latest forecast for the Global Alpha Emitter Market, projecting substantial growth through the end of the decade. According to the report, the market was valued at USD 1.30 billion in 2023 and is expected to grow to USD 3.09 billion by 2032, representing a compound annual growth rate (CAGR) of 10.10% during the 2024–2032 period. This...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Basal Cell Carcinoma Treatment Market Size Projected to Reach USD 8.96 Billion by 2032The global Basal Cell Carcinoma Treatment Market comprises the diagnosis and management solutions for Basal Cell Carcinoma, the most common form of skin cancer worldwide. BCC arises from the uncontrolled growth of basal cells, typically appearing on sun-exposed areas of the skin. Treatment modalities range from surgical removal for localized lesions to pharmacological agents and radiation...0 Commentaires 0 Parts 739 Vue 0 Aperçu
-
Cell Therapy Manufacturing Market: Global Growth & AnalysisIntrospective Market Research, a global authority in biotechnology and healthcare analysis, today released its comprehensive report on the Global Cell Therapy Manufacturing Market. This critical sector, which encompasses the complex processes of cell acquisition, culture, expansion, and testing for regenerative medicine, is transitioning from a niche laboratory process to an industrialized...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Clinical Next-Generation Sequencing Testing Market Advances Precision Medicine ApplicationsExecutive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share Forecast The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period By considering a definite base year...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Clinical Nutrition Market - Industry Growth & Trend AnalysisIntrospective Market Research, a leader in specialized healthcare market intelligence, today announced the release of its definitive report on the Global Clinical Nutrition Market. This critical sector, which ensures patients receive necessary dietary support during illness and recovery, was valued at USD 30.13 Billion in 2023. With chronic diseases and an increasing geriatric population...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Colorectal Cancer Treatment Market Advances with Targeted Therapies"Executive Summary Colorectal Cancer Treatment Market Size and Share: Global Industry Snapshot Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Research and analysis about the key...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Colorectal Cancer Treatment Market Progresses with Advances in Targeted and ImmunotherapiesRegional Overview of Executive Summary Colorectal Cancer Treatment Market by Size and Share The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. The market is valued at USD 19 billion in 2022, and it would grow upto USD 26 billion by 2030. Colorectal Cancer Treatment Market analysis gives a clear idea on various segments...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
DNA Sequencing Market - Latest Advancement And AnalysisIntrospective Market Research, a global provider of specialized market intelligence, today released a pivotal study on the global DNA Sequencing Market. The report reveals a genomic revolution underway, driven by a dramatic reduction in sequencing costs and the increasing integration of sophisticated bioinformatics. The market, which stood at USD 11.1 Billion in 2023, is forecast to reach USD...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Global Clinical NGS Testing Market Surges with Precision Medicine Growth and Faster Genetic DiagnosticsDetailed Analysis of Executive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period With this Clinical...0 Commentaires 0 Parts 820 Vue 0 Aperçu
-
Global Colorectal Cancer Treatment Market Advances with Targeted Therapies, Immunotherapy, and Early DiagnosisComprehensive Outlook on Executive Summary Colorectal Cancer Treatment Market Size and Share The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. The market is valued at USD 19 billion in 2022, and it would grow upto USD 26 billion by 2030. The insights provided in this Colorectal Cancer Treatment Market research...0 Commentaires 0 Parts 713 Vue 0 Aperçu
-
How Are New Therapies Transforming Treatment in Hodgkin Lymphoma?Global Executive Summary Hodgkin Lymphoma Drug Market: Size, Share, and Forecast CAGR Value Data Bridge Market Research analyses that the Hodgkin lymphoma drug will exhibit a CAGR of around 14.75% for the forecast period of 2022-2029 The global Hodgkin Lymphoma Drug Market analysis report gives a careful overview of the research trends for the financial year. This report studies the...0 Commentaires 0 Parts 582 Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
